ROP
38
-4
GS
76
6
KIM
50
-3
GOOG
57
2
AIV
37
-2
C
82
3
PVH
32
2
L
71
2
BK
74
5
CAT
58
-8
HCA
64
5
HD
28
-4
PNW
53
-3
AEP
61
-3
TAP
29
-11
AMAT
52
3
TJX
53
-9
KSS
62
3
REGN
59
2
CNX
49
3
ROP
38
-4
GS
76
6
KIM
50
-3
GOOG
57
2
AIV
37
-2
C
82
3
PVH
32
2
L
71
2
BK
74
5
CAT
58
-8
HCA
64
5
HD
28
-4
PNW
53
-3
AEP
61
-3
TAP
29
-11
AMAT
52
3
TJX
53
-9
KSS
62
3
REGN
59
2
CNX
49
3
Financhill
Back

CBRE Global Real Estate Income Fund Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
39

IGR
CBRE Global Real Estate Income Fund

Last Price:
$4.25
Seasonality Move:
-0.18%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.80
Seasonality Move:
11.35%
Sell
39
CBRE Global Real Estate Income Fund (IGR) is a Sell

Is CBRE Global Real Estate Income Fund a Buy, Sell or Hold?

  • The current CBRE Global Real Estate Income Fund [IGR] share price is $4.28. The Score for IGR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • IGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IGR Stock Price Chart

What is CBRE Global Real Estate Income Fund's stock price today?

  • The CBRE Global Real Estate Income Fund share price today is $4.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGR is experiencing slight selling pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

IGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 33.26 Sell
Chaikin Money Flow: -336894 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.31 - 4.65) Sell
Bollinger Bands (100): (4.6 - 5.12) Sell

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.77 Buy
Relative Strength Index (14 RSI): 85.1 Buy
Chaikin Money Flow: 991653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.01 - 220.61) Buy
Bollinger Bands (100): (55.63 - 178.69) Buy

IGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.29 Sell
20-day SMA: 4.43 Sell
50-day SMA: 4.7 Sell
200-day SMA: 4.96 Sell
8-day EMA: 4.32 Sell
20-day EMA: 4.42 Sell
50-day EMA: 4.54 Sell
200-day EMA: 3.05 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.26 Buy
20-day SMA: 220.14 Buy
50-day SMA: 161.87 Buy
200-day SMA: 73.76 Buy
8-day EMA: 220.14 Buy
20-day EMA: 210.53 Buy
50-day EMA: 173.33 Buy
200-day EMA: 94.53 Buy

CBRE Global Real Estate Income Fund Earnings Growth & IGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

CBRE Global Real Estate Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):